Home › supplemental
 

Keywords :   


Tag: supplemental

GE Healthcare Files Supplemental New Drug Application For Its Own Manufacturing Of Optison (Perflutren Protein-Type A Microspheres Injectable Suspension, USP)

2013-01-15 13:50:00| drugdiscoveryonline News Articles

GE Healthcare recently announced that it has filed a supplemental new drug application (sNDA) that will allow the company to manufacture Optison (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), within its own facility

Tags: application files drug manufacturing

 

Sites : [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35]